SAFETY DATA SHEET

1. Chemical Product and Company Identification

1.1 Product identifier
Chemical type Mixture
Trade name / designation Actysurf 435 M

1.2 Relevant identified uses of the substance and uses advised against
1.2.1 Relevant identified uses

Industrial uses;Detergent products

Professional uses; Food beverage and pharmacies products, General surface cleaning products.

1.3 Information on manufacturer/supplier/distributor

Supplier name: COSMER KİMYA A.Ş.

Address: Harmandere Mahallesi Ankara Caddesi No: 486 A Blok Daire 12 Airport Plaza Pendik/
İstanbul
Tel: 90 216 469 71 65 (Pbx)
Fax: +90 216 469 71 66

2. Hazard identification
2.1 Classification of the mixture
2.1.1 Classification according to Regulation
Eye Dam. 1
(EC) No 1272/2008 [CLP]
2.1.2 Classification according to 1999/45/EC Xi; R41
2.1.3 Additional information For full text of R-, H-phrases: see SECTION 16.

2.2 Label elements

2.2.1 Labeling according to Regulation (EC) No 1272/2008 [CLP]
Hazard pictograms

GHS05
 Signal Word Danger
Hazard Statements H318 Causes serious eye damage
Precautionary statements
P280 Wear protective gloves/protective
Prevention
clothing/eye protection/face protection.
P305 + P351 + P338 IF IN EYES: Rinse
cautiously with water for several minutes.
Response
Remove contact lenses, if present and easy to
do. Continue rinsing.
P310 Immediately call a POISON CENTER or
doctor/physician.
Storage Not applicable
Disposal Not applicable
2.2.2 Labeling according to 1999/45/EC (DPD)
Symbols and Indications of Danger

Irritant
Risk phrases
Safety phrase R41 Risk of serious damage to eyes.
S25 Avoid contact with eyes.
S26 In case of contact with eyes, rinse
immediately with plenty of water and seek
medical advice.
S39 Wear eye/face protection.
Specific concentration limits
None
2.3 Other hazards
Not known to our knowledge.

3
3. Composition/information on ingredients
3.1 Substances Not applicable

3.2 Mixtures
3.2.1 INCI name Ethylhexyl Glucoside

Classification Classification
Purity% according to according to
Name Product identifier
[weight] Directive Regulation (EC) No
67/548/EEC 1272/2008 [CLP]
D-Glucopyranose, (CAS No.)
63~67% Xi; R41 Eye Dam. 1
oligomeric,2- 161074-93-7 (EC No.)
ethylhexyl glycosides 500-529-1
1,2,3-Propanetricarboxylic (CAS No.)5949-29-1 1-4%
Xi; R41 Eye Dam. 1
acid, 2-hydroxy-, (EC No.) 611-842-9
monohydrate
(CAS No.) 7732-18-5 Not classified
Water 33~37% Not classified
(EC No.) 231-791-2
4. First-aid measures
4.1 Description of first aid measures
4.1.1 First-aid measures general No general information.
4.1.2 Following inhalation Use a bag valve mask or similar device to perform
artificial respiration (rescue breathing) if needed.
Get medical attention immediately.
4.1.3 Following skin contact Remove contaminated clothing immediately.
Wash with soap or mild detergent and large
amounts of water until
no evidence of chemical remains (at least 15-20
minutes).
Remove contaminated clothing immediately.
4.1.4 Following eye contact Wash eyes immediately with large amounts of
water.
Get medical attention immediately.
4.1.5 Following ingestion Contact local poison control center or physician
immediately.
Give large amounts of water. Allow vomiting to
occur.
4.2 Most important symptoms and effects, both acute and delayed
4.2.1 Symptoms/injuries No general information.
4.2.2 Symptoms/injuries after inhalation The material is not thought to produce either
adverse health effects or irritation of the respiratory
tract following inhalation (as classified by EC
Directives using animal models).

4
 Nevertheless, adverse systemic effects have been
produced following exposure of animals by at least
one other route and good hygiene practice requires
that exposure be kept to a minimum and that
suitable control measures be used in an
occupational setting. Inhalation of vapours may
cause drowsiness and dizziness. This may be
accompanied by sleepiness, reduced alertness,
loss of reflexes, lack of co-ordination, and vertigo.
4.2.3 Symptoms/injuries after skin contact Skin contact is not thought to have harmful health
effects (as classified under EC Directives); the
material may still produce health damage following
entry through wounds, lesions or abrasions.
There is some evidence to suggest that the
material may cause mild but significant
inflammation of the skin either following direct
contact or after a delay of some time. Repeated
exposure can cause contact dermatitis which is
characterized by redness, swelling and blistering.
Alkyl glycosides, as a family, are considered non-
irritating to the skin. Entry into the blood-stream,
through, for example, cuts, abrasions or lesions,
may produce systemic injury with harmful effects.
4.2.4 Symptoms/injuries after eye contact If applied to the eyes, this material causes severe
eye damage. Non-ionic surfactants can cause
numbing of the cornea, which masks discomfort
normally caused by other agents and leads to
corneal injury. Irritation varies depending on the
duration of contact, the nature and concentration of
the surfactant. At very high concentrations, alkyl
polyglycosides and polygalactosides are eye
irritants while some C8 alkyl glycoside solutions
may produce serious eye damage.
4.2.5 Symptoms/injuries after ingestion Accidental ingestion of the material may be
damaging to the health of the individual. Nonionic
surfactants may produce localised irritation of the
oral or gastrointestinal lining and induce vomiting
and mild diarrhoea.

4.3 Indication of any immediate medical attention and Treat symptomatically.

special treatment needed

5
5. Fire-fighting measures
5.1 Extinguishing media
Suitable extinguishing media Carbon dioxide, Regular dry chemical, Water ,
Dry powder, Fight lager fires with water spray or
alcohol resistant foam (Large fire)
Unsuitable extinguishing media None Known.

5.2 Special hazards arising from the substance or mixture

Hazardous combustion products Carbon oxide

5.3 Advice for fire-fighters

5.3.1 Fire Fighting Wear self contained breathing apparatus and
protective gear.
5.3.2 Fire/Explosion Hazard No additional information available.

6. Accidental release measures

6.1 Personal precautions, protective equipment and emergency procedures
6.1.1 For non-emergency personnel
Protective equipment Wear proper protective equipment.
Emergency procedures Contain the spilled liquid with sand or inert
absorbent material.
Avoid all possible sources of ignition (halogen,
Spark, flame).
6.1.2 For emergency responders
Personal protective equipment Compatible chemical-resistant gloves.
Chemical safety goggles.
6.2 Environmental precautions Do not allow to enter drains, sewers or
watercourses.

6.3 Methods and material for containment and cleaning up

6.3.1 For containment Wash residue from spill area with water
containing detergent and flush to a sewer
serviced by a permitted wastewater treatment
facility.
6.3.2 For cleaning up Transfer used material to a suitable waste
container and dispose of in accordance with local
regulation.
Contain spillages with sand, earth or any suitable
adsorbent material.
Wash the spillage area clean with water and
detergent.
6.3.3 Other information No additional information available.

6.4 Reference to other sections See Section 8 for information on personal

protection equipment.
See Section 13 for information on disposal.

6
7. Handling and storage
7.1 Precautions for safe handling
7.1.1 Protective measures Avoid open flames.
Do not get in eyes or on skin or clothing.
Avoid breathing vapour or mist.
Put on appropriate personal protective equipment
(see section 8).
7.1.2 Advice on general occupational hygiene Do not to eat, drink and smoke in work areas.
Wash hands and face before eating, drinking and
smoking.

7.2 Conditions for safe storage, including any incompatibilities

Store in the original closed containers under dry
7.2.1 Suitable container
conditions.
Do not store in unlabeled containers.
Keep way from incompatibles such as oxidizing
7.2.2 Storage incompatibility
agents, acids.
Avoid all possible sources of ignition (halogen,
spark, flame).
7.2.3 Storage conditions No additional information available.

7.3 Specific end use(s) No additional information available.

8. Exposure controls/personal protection
8.1 Control parameters
8.1.1 Occupational exposure limits No workplace exposure limit assigned.
8.1.2 Biological limit values No information available.
8.1.3 Exposure limit at intended use No information available.
8.1.4 DNEL/DMEL and PNEC-Values
DN(M)EL Worker:
DNEL Type DNEL Value Remark
DNEL short-term oral (acute)
DNEL long-term oral (repeated)
DNEL acute dermal, short-term (local) Assessment of hazard sufficiently
coverage by derivation of the
respective DNEL for long-term
exposure.
DNEL acute dermal, short-term (systemic) Assessment of hazard sufficiently
coverage by derivation of the
respective DNEL for long-term
exposure.
DNEL long-term dermal (local) Due to the known irritating potential
of the undiluted test substances it is
common to use personal protective
equipment like gloves to avoid
dermal contact there with
considering local DNELs as
obsolete.
DNEL long-term dermal (systemic) 595,000 mg/kg
bw/day

7
DNEL Type DNEL Value Remark
DNEL acute inhalative (local) Assessment of hazard sufficiently
coverage by derivation of the
respective DNEL for long-term
exposure.
DNEL acute inhalative (systemic) Assessment of hazard sufficiently
coverage by derivation of the
respective DNEL for long-term
exposure.
DNEL long-term inhalative (local) Assessment of hazard not
assignable due to
missing/insufficient data.
DNEL long-term inhalative (systemic) 420 mg/m3
DN(M)EL General population:
DNEL short-term oral (acute) Assessment of hazard sufficiently
covered by derivation of the
respective DNEL for long-term
exposure.
DNEL long-term oral (repeated) 35.7 mg/kg
bw/day
DNEL acute dermal, short-term (local) Assessment of hazard sufficiently
covered by derivation of the
respective DNEL for long-term
exposure.
DNEL acute dermal, short-term (systemic) Assessment of hazard sufficiently
covered by derivation of the
respective DNEL for long-term
exposure.
DNEL long-term dermal (local) Only workers will come in contact
with the neat irritating substances.
DNEL long-term dermal (systemic) 357,000 mg/kg
bw/day
DNEL acute inhalative (local) Assessment of hazard sufficiently
covered by derivation of the
respective DNEL for long-term
exposure.
DNEL acute inhalative (systemic) Assessment of hazard sufficiently
covered by derivation of the
respective DNEL for long-term
exposure.
DNEL long-term inhalative (local) Assessment of hazard not
assignable due to
missing/insufficient data.
DNEL long-term inhalative (systemic) 124 mg/m3

8
 PNEC:
PNEC Type PNEC Value Assessment Remark
factor
PNEC aquatic, fresh water 0.1 mg/L 10
PNEC aquatic, marine water 0.01 mg/L 100
PNEC aquatic, intermittent releases 0.27 mg/L 100
PNEC sediment, fresh water 0.487 mg/kg N/A
PNEC sediment, marine water 0.048 mg/kg N/A
PNEC soil 0.654 mg/kg 1000
PNEC sewage treatment plant (STP) 560 mg/L 1
PNEC air
PNEC secondary poisoning 111.11 mg/kg 90
food
8.1.5 Risk management measures according to used control banding approach
Exposure Description General measures Specific Human Specific Environment
scenario Health risk risk management
management measures
measures
AISE Formulation (i) Procedural (i) Local Exhaust (i) Treatment of
: Granular and ventilation effluent in
Detergent/Maintenance technological (LEV) biological waste
Products, liquid control using water treatment
Detergents/Maintenance Best plant
Products Available (ii) Use of air
End use Technique emission
: Industrial use of (BAT) abatement
Facade/surface Cleaning equipments
Products, Laundry products such as
and Vehicle cleaning Products, incinerators and
etc. scrubbers are
Consumer use applicable as a
: Consumer use of air best practice
freshener products, polishes,
washing and cleansing
products, pest control products,
etc.

8.2 Exposure controls

8,2,1 Appropriate engineering controls Provide exhaust ventilation.
8.2.2 Personal protective equipment
Eye/Face protection Safety glasses with side shields Chemical
goggles.
Facilities storing or utilizing this material should be
equipped with an eyewash facility and a safety
shower.
Skin protection Wear general protective gloves, e.g. light weight
rubber gloves.
Respiratory protection In dust atmospheres, use an approved dust
respirator.
Thermal hazards No information available

9
 8.2.3 Environmental exposure controls Treatment of effluent in biological waste water
treatment plant.
Use of air emission abatement equipments such
as incinerators and scrubbers are applicable as a
best practice

9. Physical and chemical properties

9.1 Information on basic physical and chemical properties
Appearance Clear, Viscous Liquid
Odour Alcohol Odour
Color Yellow
pH 2~4 (10% aq.sol’n)
Melting point/freezing point 0℃
Initial boiling point and boiling range 100 ℃
Flash point Not applicable
Evaporation rate No data available
Flammability (solid, gas) Non flammable (RA from CAS No. 54549-24-5 and
110615-47-9)
Upper/lower flammability or explosive limits No data available
Vapour pressure < 0.01 Pa at 20 ℃ (RA from CAS No. 54549-24-5
and 110615-47-9)
Vapour density No data available
Relative density 1.10 - 1.20 at 25 ℃
Solubility(ies) > 200 g/L at 20 ℃ (RA from CAS No. 54549-24-5
and 110615-47-9)
Partition coefficient n-octanol/water (Log Kow) < 1.77 (RA from CAS No. 54549-24-5 and 110615-
47-9)
Auto-ignition temperature No data available
Decomposition temperature No data available
Viscosity 100 ~ 500 cps at 25 ℃
Explosives properties Non explosive
Oxidizing properties Non oxidizing

9.2 Other information

Surface tension No data available

10. Stability and Reactivity

10.1 Reactivity Hazardous polymerization will not occur.
10.2 Chemical stability Stable under normal conditions.
Under normal conditions of storage and use,
10.3 Possibility of hazardous reactions
hazardous reactions will not occur.
10.4 Conditions to avoid Avoid heat, flames, sparks and other sources of
ignition.
10.5 Incompatible materials Metals, oxidizing materials
Thermal breakdown of this product during fire or
very high heat conditions may evolve the
10.6 Hazardous decomposition products
following decomposition products : Carbon
monoxide, Carbon dioxide

10
11. Toxicological information
11.1 Information on toxicological effects
11.1.1 Acute toxicity
Oral Acute toxicity LD50 > 2000 mg/kg (Analogy) Skin Irritation : Not
Irritating (Analogy) Eye Irritation : Severely
Irritating (Analogy) In Vitro Mutagenicity: Not
Mutagenic (Analogy)
Dermal Acute toxicity No data available.
Inhalation Acute toxicity (Vapour) No data available.
Inhalation Acute toxicity (Dust/Mist) No data available.
11.1.2 Skin corrosion/irritation Not irritating (Rabbit, OECD Guideline 404)
11.1.3 Serious eye damage/irritation Highly irritating (Rabbit, OECD Guideline 405)
11.1.4 Irritation to respiratory tract No data available.
11.1.5 Respiratory or skin sensitization Not sensitizing (Guinea pig, male, OECD
Guideline 406)
11.1.6 Germ cell mutagenicity in vitro : mouse lymphoma L5178Y cells
(mammalian cell gene mutation assay, meta. Act. :
with and without) : negative
in vitro : S. typhimurium (Ames test, OECD
Guideline 471, met.act. : with and without) :
negative
in vitro : Chinese hamster lung fibroblasts
(mammalian chromosome aberration test, OECD
Guideline 473, met. Act. : with and without) :
negative
in vivo : mouse (CD-1) male (micronucleus assay,
OECD guideline 474) : negative
11.1.7 Carcinogenicity No data available.
11.1.8 Reproductive toxicity Method : Rat male/female (one generation
screening study, oral: gavage, 0, 100, 300, 1000
mg/kg bw, exposure: 2 weeks before pairing and
continuously thereafter, up to the day before
sacrifice (study day 53, day 4 post partum). (daily),
OECD Guideline 421.
Results : NOAEL (P): 1000 mg/kg bw/day
(nominal) (male/female) (No treatment-related
effects.)
Method : Rat, oral : gavage, 0, 100, 300, 1000
mg/kg bw, exposure : day 6-15 of gestation (daily),
OECD Guideline 414
Results : NOAEL (maternal toxicity): 1000 mg/kg
bw/day (nominal) (no treatment-related effects)
NOAEL (developmental toxicity): 1000 mg/kg
bw/day (nominal) (no treatment-related effects)
11.1.9 STOT-single exposure No data available.
11.1.10 STOT-repeated exposure Method: Rat (male/female), sub chronic (oral:
gavage), 0, 250, 500, 1000 mg/kg bw (nominal in
water), Exposure: 90 days (daily), EU Method B.
26

11
 Results: NOAEL: 100 mg/kg bw/day (nominal)
(male/female) (Inflammation and ulcerations of
mucous membrane of the forestomach due to
bolus administration and irritating potential of the
test substance.)
11.1.11 Aspiration hazard No data available.

12. Ecological information

12.1 Toxicity
Acute (short-term) toxicity
Fish Acute Toxicity Fish LC50 : >1-<=10mg product/L
(Analogy) Acute Toxicity Bacterial EC0: >100mg
product/L (Analogy)

12.2 Persistence and degradability

Degradability Primary Degradation: According to the
requirements of the EU Mandatory Standards for
Detergents 82/242(Nonionic surfactants) and
82/243/EEC (Anionic surfactants) the surfactants
contained in the products are biodegradable to at
least 90% on average.
Ultimate Biodegradation: Readily and rapidly
degradable. All organic substances contained in
the product achieve >60% BOD/COD or CO2
liberation, or >70% DOC reduction tests for ease of
degradability. Threshold values for 'readily
degradable' (e.g. to OECD method 301) are
reached. (Analogy)
12.3 Bio accumulative potential
Log Kow < 1.77
12.4 Mobility in soil log Koc = 1.7 (OECD Guideline 121)
12.5 Results of PBT and vPvB assessment D-Glucopyranose, oligomeric, decyl octyl
glycosides is not a candidate for PBT or vPvB
classification.
12.6 Other adverse effects No additional information available.

13. Disposal consideration

13.1 Waste treatment methods Small amounts may be diluted with plenty of water
and washed away.
Waste incineration with the approval of the
responsible local authority.

12
14. Transport information
14.1 UN number None as product is not classified.
14.2 UN proper shipping name None as product is not classified.
14.3 Transport hazard class(es) None as product is not classified.
14.4 Packing group None as product is not classified.
14.5 Environmental hazard None as product is not classified.
14.6 Special precautions for user None as product is not classified.
14.7 Transport in bulk according to Annex II of MARPOL None as product is not classified.
73/78 and the IBC Code

15. Regulatory information

15.1 Safety, health and environmental regulations/legislation specific for the substance or mixture
15.1.1 EU regulations
Authorizations and/or restrictions on use:
Authorization Not applicable.
Restrictions on use Not applicable.
Other EU regulations Not applicable.

15.1.2 National regulations No additional information available.

15.2 Chemical Safety Assessment No additional information available.

16. Other information

Version 1.0 - The SDS format was established
16.1 Indication of changes according to the REGULATION (EU) N°
453/2010.
16.2 Abbreviations and acronyms
1272/2008 CLP Classification, Labeling and Packaging regulation.
REACH Registration, Evaluation and authorization of chemical substances.
DNEL Derive no effects level.
PENC Predicted no effect concentration.
16.3 Key literature references and sources for data
Chemical Safety Report – D-Glucopyranose, oligomeric, decyl glycosides
eChemPortal, OECD
REACH-IT
RightAnswer
IUCLID

13
 OECD SIDS
ECOTOX
NITE
Recommendations on the transport of dangerous goods
Emergency response guide book
EU RAR
The chemical database
HSDB
IARC
ICSC

16.4 Classification for mixtures and used evaluation method according to regulation (EC) 1207/2008 (CLP)
D-Glucopyranose, oligomeric, decyl glycosides
Classification according to Regulation (EC) 1207/2008 Classification procedure
Eye Dam. 1 Calculation method

16.5 Relevant R- and H-phrases (number and full text) R41 Risk of serious damage to eyes.
16.6 Training advice No specific information
16.7 Further information
Original MSDS established April 25, 2020

The (M)SDS is a Hazard Communication tool and should be used to assist in the Risk Assessment.
Many factors determine whether the reported Hazards are Risks in the workplace or other settings. Risks
may be determined by reference to Exposures Scenarios. Scale of use, frequency of use and current or
available engineering controls must be considered.

14